Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones
Extraintestinal pathogenic Escherichia coli (ExPEC) is the main cause of urinary tract infections and septicemia. Significant attention has been given to the ExPEC sequence type ST131, which has been categorized as a “high-risk” clone. High-risk clones are globally distributed clones associated with...
Saved in:
| Published in: | mSphere Vol. 3; no. 4 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
American Society for Microbiology
18.07.2018
|
| Subjects: | |
| ISSN: | 2379-5042, 2379-5042 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Extraintestinal pathogenic
Escherichia coli
(ExPEC) is the main cause of urinary tract infections and septicemia. Significant attention has been given to the ExPEC sequence type ST131, which has been categorized as a “high-risk” clone. High-risk clones are globally distributed clones associated with various antimicrobial resistance determinants, ease of transmission, persistence in hosts, and effective transmission between hosts. The high-risk clones have enhanced pathogenicity and cause severe and/or recurrent infections. We show that clones of the
E. coli
ST410 lineage persist and/or cause recurrent infections in humans, including bloodstream infections. We found evidence of ST410 being a highly resistant globally distributed lineage, capable of patient-to-patient transmission causing hospital outbreaks. Our analysis suggests that the ST410 lineage should be classified with the potential to cause new high-risk clones. Thus, with the clonal expansion over the past decades and increased antimicrobial resistance to last-resort treatment options, ST410 needs to be monitored prospectively.
Escherichia coli
sequence type 410 (ST410) has been reported worldwide as an extraintestinal pathogen associated with resistance to fluoroquinolones, third-generation cephalosporins, and carbapenems. In the present study, we investigated national epidemiology of ST410
E. coli
isolates from Danish patients. Furthermore,
E. coli
ST410 was investigated in a global context to provide further insight into the acquisition of the carbapenemase genes
bla
OXA-181
and
bla
NDM-5
of this successful lineage. From 127 whole-genome-sequenced isolates, we reconstructed an evolutionary framework of
E. coli
ST410 which portrays the antimicrobial-resistant clades B2/H24R, B3/H24Rx, and B4/H24RxC. The B2/H24R and B3/H24Rx clades emerged around 1987, concurrently with the C1/H30R and C2/H30Rx clades in
E. coli
ST131. B3/H24Rx appears to have evolved by the acquisition of the extended-spectrum β-lactamase (ESBL)-encoding gene
bla
CTX-M-15
and an IncFII plasmid, encoding IncFIA and IncFIB. Around 2003, the carbapenem-resistant clade B4/H24RxC emerged when ST410 acquired an IncX3 plasmid carrying a
bla
OXA-181
carbapenemase gene. Around 2014, the clade B4/H24RxC acquired a second carbapenemase gene,
bla
NDM-5
, on a conserved IncFII plasmid. From an epidemiological investigation of 49
E. coli
ST410 isolates from Danish patients, we identified five possible regional outbreaks, of which one outbreak involved nine patients with
bla
OXA-181
- and
bla
NDM-5
-carrying B4/H24RxC isolates. The accumulated multidrug resistance in
E. coli
ST410 over the past two decades, together with its proven potential of transmission between patients, poses a high risk in clinical settings, and thus,
E. coli
ST410 should be considered a lineage with emerging “high-risk” clones, which should be monitored closely in the future.
IMPORTANCE
Extraintestinal pathogenic
Escherichia coli
(ExPEC) is the main cause of urinary tract infections and septicemia. Significant attention has been given to the ExPEC sequence type ST131, which has been categorized as a “high-risk” clone. High-risk clones are globally distributed clones associated with various antimicrobial resistance determinants, ease of transmission, persistence in hosts, and effective transmission between hosts. The high-risk clones have enhanced pathogenicity and cause severe and/or recurrent infections. We show that clones of the
E. coli
ST410 lineage persist and/or cause recurrent infections in humans, including bloodstream infections. We found evidence of ST410 being a highly resistant globally distributed lineage, capable of patient-to-patient transmission causing hospital outbreaks. Our analysis suggests that the ST410 lineage should be classified with the potential to cause new high-risk clones. Thus, with the clonal expansion over the past decades and increased antimicrobial resistance to last-resort treatment options, ST410 needs to be monitored prospectively. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Citation Roer L, Overballe-Petersen S, Hansen F, Schønning K, Wang M, Røder BL, Hansen DS, Justesen US, Andersen LP, Fulgsang-Damgaard D, Hopkins KL, Woodford N, Falgenhauer L, Chakraborty T, Samuelsen Ø, Sjöström K, Johannesen TB, Ng K, Nielsen J, Ethelberg S, Stegger M, Hammerum AM, Hasman H. 2018. Escherichia coli sequence type 410 is causing new international high-risk clones. mSphere 3:e00337-18. https://doi.org/10.1128/mSphere.00337-18. |
| ISSN: | 2379-5042 2379-5042 |
| DOI: | 10.1128/mSphere.00337-18 |